v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Cash flows from operating activities    
Net income (loss) $ 22,525 $ (22,555)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 7,509 3,253
Amortization of deferred contract acquisition costs 24,116 21,324
Net accretion on marketable securities (701) (3,630)
Stock-based compensation expense 53,310 76,361
Charitable donation of Class A common stock 3,015 4,187
Non-cash operating lease expense 4,317 3,377
Provision for deferred income taxes 11,391 640
Change in fair value of contingent consideration 2,446 0
Other non-cash (credits) charges, net (829) 12,704
Changes in operating assets and liabilities:    
Accounts receivable 194,865 197,443
Contract assets (13,977) (9,460)
Deferred contract acquisition costs (26,645) (13,954)
Prepaid expenses and other assets (12,870) (13,074)
Accounts payable 9,390 (15,025)
Accrued expenses and other liabilities (24,991) 12,352
Accrued compensation and employee benefits (61,062) (72,534)
Operating lease liabilities, net (4,458) (2,146)
Deferred revenue (55,423) (60,261)
Net cash provided by operating activities 131,928 119,002
Cash flows from investing activities    
Purchases of marketable securities (154,971) (153,353)
Maturities of marketable securities 189,592 111,083
Purchases of property and equipment (2,684) (12,832)
Payments related to business acquisitions, net of cash acquired (149,403) (24,821)
Other investing, net 4,625 0
Net cash used in investing activities (112,841) (79,923)
Cash flows from financing activities    
Repurchases of Class A common stock (243,796) (227,525)
Proceeds from exercise of stock options 349 302
Payments of tax withholdings on settlement of equity awards (12,770) (12,195)
Proceeds from employee stock purchase plan contributions 4,026 4,214
Net cash used in financing activities (252,191) (235,204)
Effect of exchange rate changes (4,821) 17,570
Net decrease in cash, cash equivalents, and restricted cash (237,925) (178,555)
Cash, cash equivalents, and restricted cash - beginning of period 871,595 879,634
Cash, cash equivalents, and restricted cash - end of period 633,670 701,079
Supplemental disclosure of cash flow information    
Cash paid for income taxes, net 4,974 6,052
Supplemental disclosure of non-cash investing and financing activities    
Property and equipment purchases included in accounts payable 60 63
Contingent and deferred consideration recognized in connection with business acquisitions 30,000 9,835
Tax withholdings on net settlement of restricted stock units, accrued but not yet paid $ 5,845 $ 3,136